DOCSLIB.ORG

Hedgehog Signalling in the Tumourigenesis and Metastasis of Osteosarcoma, and Its Potential Value in the Clinical Therapy Of

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hedgehog Signalling in the Tumourigenesis and Metastasis of Osteosarcoma, and Its Potential Value in the Clinical Therapy Of Yao et al. Cell Death and Disease (2018) 9:701 DOI 10.1038/s41419-018-0647-1 Cell Death & Disease REVIEW ARTICLE Open Access Hedgehog signalling in the tumourigenesis and metastasis of osteosarcoma, and its potential value in the clinical therapy of osteosarcoma Zhihong Yao1,LeiHan1, Yongbin Chen2,FeiHe3,BinSun3, Santosh kamar1, Ya Zhang1,YihaoYang1, Cao Wang1 and Zuozhang Yang1 Abstract The Hedgehog (Hh) signalling pathway is involved in cell differentiation, growth and tissue polarity. This pathway is also involved in the progression and invasion of various human cancers. Osteosarcoma, a subtype of bone cancer, is commonly seen in children and adolescents. Typically, pulmonary osteosarcoma metastases are especially difficult to control. In the present paper, we summarise recent studies on the regulation of osteosarcoma progression and metastasis by downregulating Hh signalling. We also summarise the crosstalk between the Hh pathway and other cancer-related pathways in the tumourigenesis of various cancers. We further summarise and highlight the therapeutic value of potential inhibitors of Hh signalling in the clinical therapy of human cancers. 1234567890():,; 1234567890():,; Facts Open questions ● The Hh pathway regulates the progression of ● How does the Hh pathway regulate the tumourigenic osteosarcoma. progression and invasion of human osteosarcoma? ● The Hh pathway is involved in the metastasis of ● How does the Hh pathway interact with other osteosarcoma into other organs, such as the lungs. cancer-related pathways in the progression and ● The Hh pathway crosstalks with other cancer-related metastasis of cancers? pathways in the tumourigenesis of cancers. ● Could the Hh pathway be used as a target or ● The therapeutic value of the Hh pathway in the biomarker in clinical therapy for human clinical therapy of osteosarcoma is summarised. osteosarcoma? Introduction Correspondence: Zuozhang Yang ([email protected]) Osteosarcoma, which is a malignant bone tumour with 1Department of Orthopaedics, Bone and Soft Tissue Tumors Research Center of Yunnan Province, The Third Affiliated Hospital of Kunming Medical locally aggressive growth and high metastatic potential, is University (Tumor Hospital of Yunnan Province), Kunming, Yunnan 650118, one of the most commonly observed diseases1. Distant China 2 metastases of osteosarcoma, such as lung metastases, are Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming 2 Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, hard to control and usually have a poor prognosis . The China survival rate of osteosarcoma patients has gradually Full list of author information is available at the end of the article. These authors contributed equally: Zhihong Yao, Lei Han, Yongbin Chen, Fei He. Edited by A. Oberst © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a linktotheCreativeCommons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Official journal of the Cell Death Differentiation Association Yao et al. Cell Death and Disease (2018) 9:701 Page 2 of 12 improved3. However, ~20% of osteosarcoma patients organisms. Briefly, the core constituents of the Hh/Gli continue to present with lung metastases at diagnosis, and pathway in Drosophila are the Hh ligand; Ptc; cubitus the 5-year survival rate has not significantly increased4. interruptus (Ci); Smo; and signal transducers, such as Cos2, – An exact description of the molecular basis of the pro- Fused (Fu), or SuFu(Fig. 1)19 23. In higher organisms, the liferation and metastasis of osteosarcoma will help in the core constituents of Hh signalling are more complex, clinical treatment of osteosarcoma and improvement of comprising three Hh ligands, Sonic hedgehog (Shh), Desert patient survival. hedgehog (Dhh) and Indian hedgehog (Ihh); two twelve- Hedgehog (Hh)/Gli signalling is a conserved signal pass transmembrane receptors, Patched1 (PTCH1) and transduction pathway that possesses a key regulatory Patched2 (PTCH2); Smo; and three transcription factors, – function in physiological processes, including embryonic including GLI1, GLI2 and GLI3(Fig. 2)24 27. The three Gli development, tissue differentiation and cell growth5,6. nuclear transcription factors are highly similar in amino Recently, the Hh pathway was found to possess a key acid sequence. Usually, Gli1 is involved in transcriptional function in the progression and metastasis of various activation, while Gli2 and Gli3 can both activate and inhibit – – cancers7 10. The Hh/Gli signalling pathway mainly transcription28 30. Three homologous Hh ligands and Ptch includes the Hh ligand, its twelve-pass transmembrane can be combined and can perform different biological protein receptor Patched (Ptc), the seven-pass trans- functions during different stages of cancer progression. membrane protein Smoothened (Smo), and cytoplasmic The target genes of the Hh pathway involve different proteins involved in the Hh signalling protein complex, physiological processes, including stem cell formation and including Fused kinase, Costal-2 (Cos2), GSK3 beta, PKA, tumour cell invasion31,32 (Fig. 1). Fu suppressor protein (SuFu) and nuclear factor glioma- Briefly, in the Hh pathway, in the absence of the Hh associated oncogene transcription factors, which are key ligand, the cell surface receptor Ptc binds to Smo and downstream regulators in this signalling pathway and effectively suppresses Smo activity, inhibiting the activa- – have a pivotal role in signal transduction11 13. Target tion of Hh signalling33,34. At this point, Gli3 is phos- genes in the Hh pathway are related to cell proliferation, phorylated and hydrolysed by proteolytic enzymes, survival, cell cycle, stem cell formation, cell invasion and releasing the transcriptional repressor protein Gli3 into many other processes12 the nuclear area and ultimately inhibiting the levels of the In the present paper, we summarise the mechanism via Hh target genes35. When the Hh ligand is present, it which Hh/Gli signalling is regulated in the tumourigen- interacts with the receptor Ptch, initiating the classical Hh esis and metastasis of cancers, focusing on the impact of pathway. Hh induces the phosphorylation of multiple Ser/ these regulatory activities on the progression, invasion Thr residues at the carboxy terminus of Smo, resulting in – and metastasis of osteosarcoma. We also discuss the the release of Smo inhibition by Ptch28,36 38. Smo is interaction between the Hh/Gli pathway and other recruited and activated on the cell surface, which finally cancer-related signalling pathways during the progression activates the cytoplasmic protein complex to activate the of human cancers. At the end of this review, we highlight Hh signalling pathway39. The signal is transduced to Gli the therapeutic value of Hh pathway inhibitors in the factor, which transports the signal to the cell nucleus and clinical therapy of human cancers, describe future chal- regulates the transcription of related genes involved in key lenges and propose possible directions for the Hh/Gli cellular processes40. signalling-associated clinical treatment of osteosarcoma patients based on our current understanding. Regulation of the Hh pathway (miRNA, lncRNA, protein) Aberrant activation of the Hh pathway leads to the Introduction of Hedgehog signalling pathway tumourigenesis and metastasis of human cancers, such as Overview medulloblastoma, osteosarcoma, and gastric, lung, breast, Hh is a segmented polar gene that encodes a highly colorectal and prostate cancers (Fig. 2). The Hh pathway conserved secreted glycoprotein named for the bristly controls tumourigenesis and tumour invasiveness in var- phenotype of the mutation of the gene in Drosophila.Itwas ious cancers. An increasing number of agents effectively first identified in systematic searches for embryonic lethal regulate signal transduction in the Hh signalling pathway; mutants of Drosophila melanogaster by Nusslein-Volhard, these agents include proteins, compounds, and noncoding C. in 198014. The Hh/Gli pathway has a key regulatory RNA such as miRNA and lncRNA. Elucidation of the function in physiological processes15. The Hh pathway is molecular basis of Hh signalling is beneficial and will help an important signalling pathway in the carcinogenesis and guide the clinical treatment of human cancers and – metastasis of several types of cancer16 18.Thispathwayis screening of effective inhibitors to inhibit the inap- highly conserved and comprises some components that are propriate activation of the Hh pathway. Some of the regulated by post-translational events; however, there are important regulators in the Hh signalling pathway are some differences between Drosophila and higher summarised here and are shown in Fig. 3. Official journal of the Cell Death Differentiation Association Yao
Load more

Recommended publications
  • Hedgehog Signaling Is Evolutionarily Conserved Cilium-Independent
    Downloaded from genesdev.cshlp.org on August 14, 2009 - Published by Cold Spring Harbor Laboratory Press Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved Miao-Hsueh Chen, Christopher W. Wilson, Ya-Jun Li, et al. Genes Dev. 2009 23: 1910-1928 Access the most recent version at doi:10.1101/gad.1794109 Supplemental http://genesdev.cshlp.org/content/suppl/2009/07/23/23.16.1910.DC1.html Material References This article cites 97 articles, 47 of which can be accessed free at: http://genesdev.cshlp.org/content/23/16/1910.full.html#ref-list-1 Email alerting Receive free email alerts when new articles cite this article - sign up in the box at the service top right corner of the article or click here To subscribe to Genes & Development go to: http://genesdev.cshlp.org/subscriptions Copyright © 2009 by Cold Spring Harbor Laboratory Press Downloaded from genesdev.cshlp.org on August 14, 2009 - Published by Cold Spring Harbor Laboratory Press Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved Miao-Hsueh Chen,1,3 Christopher W. Wilson,1,3 Ya-Jun Li,1 Kelvin King Lo Law,2 Chi-Sheng Lu,1 Rhodora Gacayan,1 Xiaoyun Zhang,2 Chi-chung Hui,2 and Pao-Tien Chuang1,4 1Cardiovascular Research Institute, University of California at San Francisco, San Francisco, California 94158, USA; 2Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, and Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5G 1L7, Canada A central question in Hedgehog (Hh) signaling is how evolutionarily conserved components of the pathway might use the primary cilium in mammals but not fly.
    [Show full text]
  • GLI1-Amplifications Expand the Spectrum of Soft Tissue Neoplasms Defined by GLI1 Gene Fusions
    Modern Pathology (2019) 32:1617–1626 https://doi.org/10.1038/s41379-019-0293-x ARTICLE GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions 1 1 1 2 3 Narasimhan P. Agaram ● Lei Zhang ● Yun-Shao Sung ● Samuel Singer ● Todd Stevens ● 3 4 5 6 6 Carlos N. Prieto-Granada ● Justin A. Bishop ● Benjamin A. Wood ● David Swanson ● Brendan C. Dickson ● Cristina R. Antonescu1 Received: 18 February 2019 / Revised: 29 April 2019 / Accepted: 1 May 2019 / Published online: 12 June 2019 © United States & Canadian Academy of Pathology 2019 Abstract GLI1 fusions involving ACTB, MALAT1, and PTCH1 genes have been recently reported in a subset of malignant soft tissue tumors with characteristic monomorphic nested epithelioid morphology and frequent S100 positivity. However, we encountered a group of morphologically similar soft tissue tumors lacking the canonical GLI1 gene fusions and sought to investigate their genetic abnormalities. A combined approach including RNA sequencing, targeted exome sequencing and FISH methodologies were used to identify potential novel genetic abnormalities. Ten patients (five females, five males) with – fi 1234567890();,: 1234567890();,: an age range of 4 65 years (median 32.5) were identi ed. Tumors were located in the soft tissues of the limbs, trunk and head and neck, with one each in the tongue and lung. Histologically, tumors revealed ovoid to epithelioid cells arranged in a distinctive nested-trabecular pattern, separated by thin septa and a delicate vascular network. Two cases showed areas of increased nuclear pleomorphism and focal fascicular spindle cell growth. Four tumors showed a high mitotic count (≥15/10 HPFs), with necrosis seen in three of them.
    [Show full text]
  • Gli Transcription Factors Mediate the Oncogenic Transformation of Prostate Basal Cells Induced by a Kras-Androgen Receptor Axis*
    crossmark THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 291, NO. 49, pp. 25749–25760, December 2, 2016 © 2016 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A. Gli Transcription Factors Mediate the Oncogenic Transformation of Prostate Basal Cells Induced by a Kras-Androgen Receptor Axis*□S Received for publication, August 12, 2016, and in revised form, September 28, 2016 Published, JBC Papers in Press, October 19, 2016, DOI 10.1074/jbc.M116.753129 Meng Wu‡, Lishann Ingram‡, Ezequiel J. Tolosa§, Renzo E. Vera§, Qianjin Li‡, Sungjin Kim‡, Yongjie Ma‡, Demetri D. Spyropoulos¶, Zanna Beharryʈ, Jiaoti Huang**, Martin E. Fernandez-Zapico§, and Houjian Cai‡1 From the ‡Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602, the §Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, the ¶Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, the ʈDepartment of Chemistry and Physics, Florida Gulf Coast University, Fort Myers, Florida 33965, and the **Department of Pathology, School of Medicine, Duke University, Durham, North Carolina 27710 Edited by Eric Fearon Although the differentiation of oncogenically transformed cer progression has been characterized with multiple stages, 2 basal progenitor cells is one of the key steps in prostate tumori- including benign, prostatic intraepithelial neoplasia (PIN), Downloaded from genesis, the mechanisms mediating this cellular process are still invasive adenocarcinoma, and metastatic cancer (2). Numerous ؉ largely unknown. Here we demonstrate that an expanded p63 oncogenic driver genes, including loss of tumor suppressors, ؉ and CK5 basal/progenitor cell population, induced by the con- overexpression, and/or activation of oncogenes, have been comitant activation of oncogenic Kras(G12D) and androgen identified based on genetic analysis of clinical prostate tumors.
    [Show full text]
  • Non-Canonical Activation of Hedgehog in Prostate Cancer Cells Mediated by the Interaction of Transcriptionally Active Androgen Receptor Proteins with Gli3
    Oncogene (2018) 37:2313–2325 https://doi.org/10.1038/s41388-017-0098-7 ARTICLE Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3 1 1,2 2 1 1 1 2,3 Na Li ● Sarah Truong ● Mannan Nouri ● Jackson Moore ● Nader Al Nakouzi ● Amy Anne Lubik ● Ralph Buttyan Received: 19 July 2017 / Revised: 18 October 2017 / Accepted: 29 November 2017 / Published online: 12 February 2018 © The Author(s) 2018. This article is published with open access Abstract Hedgehog (Hh) is an oncogenic signaling pathway that regulates the activity of Gli transcription factors. Canonical Hh is a Smoothened-(Smo-) driven process that alters the post-translational processing of Gli2/Gli3 proteins. Though evidence supports a role for Gli action in prostate cancer (PCa) cell growth and progression, there is little indication that Smo is involved. Here we describe a non-canonical means for activation of Gli transcription in PCa cells mediated by the binding of transcriptionally-active androgen receptors (ARs) to Gli3. Androgens stimulated reporter expression from a Gli-dependent promoter in a variety of AR + PCa cells and this activity was suppressed by an anti-androgen, Enz, or by AR knockdown. 1234567890();,: Androgens also upregulated expression of endogenous Gli-dependent genes. This activity was associated with increased intranuclear binding of Gli3 to AR that was antagonized by Enz. Fine mapping of the AR binding domain on Gli2 showed that AR recognizes the Gli protein processing domain (PPD) in the C-terminus. Mutations in the arginine-/serine repeat elements of the Gli2 PPD involved in phosphorylation and ubiquitinylation blocked the binding to AR.
    [Show full text]
  • The Role of Gli3 in Inflammation
    University of New Hampshire University of New Hampshire Scholars' Repository Doctoral Dissertations Student Scholarship Winter 2020 THE ROLE OF GLI3 IN INFLAMMATION Stephan Josef Matissek University of New Hampshire, Durham Follow this and additional works at: https://scholars.unh.edu/dissertation Recommended Citation Matissek, Stephan Josef, "THE ROLE OF GLI3 IN INFLAMMATION" (2020). Doctoral Dissertations. 2552. https://scholars.unh.edu/dissertation/2552 This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more information, please contact [email protected]. THE ROLE OF GLI3 IN INFLAMMATION BY STEPHAN JOSEF MATISSEK B.S. in Pharmaceutical Biotechnology, Biberach University of Applied Sciences, Germany, 2014 DISSERTATION Submitted to the University of New Hampshire in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy In Biochemistry December 2020 This dissertation was examined and approved in partial fulfillment of the requirement for the degree of Doctor of Philosophy in Biochemistry by: Dissertation Director, Sherine F. Elsawa, Associate Professor Linda S. Yasui, Associate Professor, Northern Illinois University Paul Tsang, Professor Xuanmao Chen, Assistant Professor Don Wojchowski, Professor On October 14th, 2020 ii ACKNOWLEDGEMENTS First, I want to express my absolute gratitude to my advisor Dr. Sherine Elsawa. Without her help, incredible scientific knowledge and amazing guidance I would not have been able to achieve what I did. It was her encouragement and believe in me that made me overcome any scientific struggles and strengthened my self-esteem as a human being and as a scientist.
    [Show full text]
  • The Adrenal Capsule Is a Signaling Center Controlling Cell Renewal and Zonation Through Rspo3
    Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press RESEARCH COMMUNICATION The permanent cortex is formed through recruitment of The adrenal capsule is a capsular cells in a process that involves SHH signaling signaling center controlling (King et al. 2009). By E17.5, steroidogenic cells have adopted specific expression profiles, with the outermost cell renewal and zonation cell layers (zona glomerulosa [ZG]) producing enzymes Rspo3 that are required for mineralocorticoid production (e.g., through CYP11B2), and deeper layers (zona fasciculata [ZF]) Valerie Vidal,1,2,3,9 Sonia Sacco,1,2,3,9 expressing genes involved in glucocorticoid synthesis Ana Sofia Rocha,1,2,3,8 Fabio da Silva,1,2,3 (Cyp11b1). In humans, but not rodents, a third layer (zona reticularis) can be distinguished that produces an- Clara Panzolini,1,2,3 Typhanie Dumontet,4,5 1,2,3 6 drogens and is located close to the medulla. Several lines Thi Mai Phuong Doan, Jingdong Shan, of evidence suggest that β-catenin plays an important Aleksandra Rak-Raszewska,6 Tom Bird,7 role in adrenal zonation and maintenance. Activation of Seppo Vainio,6 Antoine Martinez,4,5 the β-catenin pathway is restricted to the ZG (Kim et al. and Andreas Schedl1,2,3 2008; Walczak et al. 2014), and ectopic expression leads to the activation of ZG markers in ZF cells (Berthon 1Institute of Biology Valrose, Université de Nice-Sophia, F-06108 et al. 2010). Moreover, β-catenin seems to bind to and con- Nice, France; 2UMR1091, Institut National de la Santé et de la trol the expression of At1r, a gene specifically expressed Recherche Médicale, F-06108 Nice, France; 3CNRS, UMR7277, within the ZG (Berthon et al.
    [Show full text]
  • GLI3 Knockdown Decreases Stemness, Cell Proliferation and Invasion in Oral Squamous Cell Carcinoma
    2458 INTERNATIONAL JOURNAL OF ONCOLOGY 53: 2458-2472, 2018 GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma MARIA FERNANDA SETÚBAL DESTRO RODRIGUES1,2, LUCYENE MIGUITA2, NATHÁLIA PAIVA DE ANDRADE2, DANIELE HEGUEDUSCH2, CAMILA OLIVEIRA RODINI3, RAQUEL AJUB MOYSES4, TATIANA NATASHA TOPORCOV5, RICARDO RIBEIRO GAMA6, ELOIZA ELENA TAJARA7 and FABIO DAUMAS NUNES2 1Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University (UNINOVE), São Paulo 01504000; 2Department of Oral Pathology, School of Dentistry, University of São Paulo, São Paulo 05508000; 3Department of Biological Sciences, Bauru School of Dentistry, Bauru 17012901; 4Department of Head and Neck Surgery, School of Medicine, 5School of Public Health, University of São Paulo, São Paulo 03178200; 6Department of Head and Neck Surgery, Barretos Cancer Hospital, Barretos 014784400; 7Department of Molecular Biology, School of Medicine of São José do Rio Preto, São José do Rio Preto 15090000, Brazil Received February 28, 2018; Accepted June 29, 2018 DOI: 10.3892/ijo.2018.4572 Abstract. Oral squamous cell carcinoma (OSCC) is an expression of the Involucrin (IVL) and S100A9 genes. Cellular extremely aggressive disease associated with a poor prognosis. proliferation and invasion were inhibited following GLI3 Previous studies have established that cancer stem cells (CSCs) knockdown. In OSCC samples, a high GLI3 expression was actively participate in OSCC development, progression and associated with tumour size but not with prognosis. On the resistance to conventional treatments. Furthermore, CSCs whole, the findings of this study demonstrate for the first time, frequently exhibit a deregulated expression of normal stem at least to the best of our knowledge, that GLI3 contributes cell signalling pathways, thereby acquiring their distinctive to OSCC stemness and malignant behaviour.
    [Show full text]
  • Tamoxifen Resistance: Emerging Molecular Targets
    International Journal of Molecular Sciences Review Tamoxifen Resistance: Emerging Molecular Targets Milena Rondón-Lagos 1,*,†, Victoria E. Villegas 2,3,*,†, Nelson Rangel 1,2,3, Magda Carolina Sánchez 2 and Peter G. Zaphiropoulos 4 1 Department of Medical Sciences, University of Turin, Turin 10126, Italy; [email protected] 2 Faculty of Natural Sciences and Mathematics, Universidad del Rosario, Bogotá 11001000, Colombia; [email protected] 3 Doctoral Program in Biomedical Sciences, Universidad del Rosario, Bogotá 11001000, Colombia 4 Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge 14183, Sweden; [email protected] * Correspondence: [email protected] (M.R.-L.); [email protected] (V.E.V.); Tel.: +39-01-1633-4127 (ext. 4388) (M.R.-L.); +57-1-297-0200 (ext. 4029) (V.E.V.); Fax: +39-01-1663-5267 (M.R.-L.); +57-1-297-0200 (V.E.V.) † These authors contributed equally to this work. Academic Editor: William Chi-shing Cho Received: 5 July 2016; Accepted: 16 August 2016; Published: 19 August 2016 Abstract: 17β-Estradiol (E2) plays a pivotal role in the development and progression of breast cancer. As a result, blockade of the E2 signal through either tamoxifen (TAM) or aromatase inhibitors is an important therapeutic strategy to treat or prevent estrogen receptor (ER) positive breast cancer. However, resistance to TAM is the major obstacle in endocrine therapy. This resistance occurs either de novo or is acquired after an initial beneficial response. The underlying mechanisms for TAM resistance are probably multifactorial and remain largely unknown. Considering that breast cancer is a very heterogeneous disease and patients respond differently to treatment, the molecular analysis of TAM’s biological activity could provide the necessary framework to understand the complex effects of this drug in target cells.
    [Show full text]
  • GLI2 but Not GLI1/GLI3 Plays a Central Role in the Induction of Malignant Phenotype of Gallbladder Cancer
    ONCOLOGY REPORTS 45: 997-1010, 2021 GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer SHU ICHIMIYA1, HIDEYA ONISHI1, SHINJIRO NAGAO1, SATOKO KOGA1, KUKIKO SAKIHAMA2, KAZUNORI NAKAYAMA1, AKIKO FUJIMURA3, YASUHIRO OYAMA4, AKIRA IMAIZUMI1, YOSHINAO ODA2 and MASAFUMI NAKAMURA4 Departments of 1Cancer Therapy and Research, 2Anatomical Pathology, 3Otorhinolaryngology and 4Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812‑8582, Japan Received August 10, 2020; Accepted December 7, 2020 DOI: 10.3892/or.2021.7947 Abstract. We previously reported that Hedgehog (Hh) signal Introduction was enhanced in gallbladder cancer (GBC) and was involved in the induction of malignant phenotype of GBC. In recent Gallbladder cancer (GBC) is the seventh most common gastro- years, therapeutics that target Hh signaling have focused on intestinal carcinoma and accounts for 1.2% of all cancer cases molecules downstream of smoothened (SMO). The three tran- and 1.7% of all cancer-related deaths (1). GBC develops from scription factors in the Hh signal pathway, glioma-associated metaplasia to dysplasia to carcinoma in situ and then to invasive oncogene homolog 1 (GLI1), GLI2, and GLI3, function down- carcinoma over 5‑15 years (2). During this time, GBC exhibits stream of SMO, but their biological role in GBC remains few characteristic symptoms, and numerous cases have already unclear. In the present study, the biological significance of developed into locally advanced or metastasized cancer by the GLI1, GLI2, and GLI3 were analyzed with the aim of devel- time of diagnosis. Gemcitabine (GEM), cisplatin (CDDP), and oping novel treatments for GBC.
    [Show full text]
  • What You Can Learn from One Gene: GLI3 L G Biesecker
    465 REVIEW J Med Genet: first published as 10.1136/jmg.2004.029181 on 1 June 2006. Downloaded from What you can learn from one gene: GLI3 L G Biesecker ............................................................................................................................... J Med Genet 2006;43:465–469. doi: 10.1136/jmg.2004.029181 The study of patients with rare multiple congenital anomaly several genes that cause abnormal phenotypes in the human when mutated (for example, SHH, syndromes can provide illuminating insights into normal PTC1, and CBP).7 development and the pathogenesis of congenital The understanding of the pathogenesis of GLI3 anomalies. The GLI3 gene is a particularly good example was markedly facilitated by analyses of model organisms and comparing the model organism as it illuminates the phenomena of pleiotropy, data with the human data. The bifunctional phenocopies, syndrome families, and evolutionary nature of GLI3 was a hypothesis based on two conservation of pathogenesis, and raises questions about observations: the biological function of cubitus interruptus (ci, the homologue of the GLI gene how diagnoses are conceptualised. These topics are family in Drosophila) and the position of trunca- reviewed in turn, in the context of the clinical and biological tion mutations in GLI3 in humans. The key data derived from patients with mutations in GLI3 and biological insight was made by the Kornberg group, when they showed that ci, which nor- experimental work in model systems. mally localises to the cytoplasm, is under
    [Show full text]
  • Mir-506 Acts As a Tumor Suppressor by Directly Targeting the Hedgehog Pathway Transcription Factor Gli3 in Human Cervical Cancer
    Oncogene (2015) 34, 717–725 © 2015 Macmillan Publishers Limited All rights reserved 0950-9232/15 www.nature.com/onc ORIGINAL ARTICLE miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer S-Y Wen1,2,3,8, Y Lin2,8, Y-Q Yu4, S-J Cao5, R Zhang6, X-M Yang3,JLi3, Y-L Zhang3, Y-H Wang3, M-Z Ma3, W-W Sun5, X-L Lou5, J-H Wang7, Y-C Teng1 and Z-G Zhang3 Although significant advances have recently been made in the diagnosis and treatment of cervical carcinoma, the long-term survival rate for advanced cervical cancer remains low. Therefore, an urgent need exists to both uncover the molecular mechanisms and identify potential therapeutic targets for the treatment of cervical cancer. MicroRNAs (miRNAs) have important roles in cancer progression and could be used as either potential therapeutic agents or targets. miR-506 is a component of an X chromosome- linked miRNA cluster. The biological functions of miR-506 have not been well established. In this study, we found that miR-506 expression was downregulated in approximately 80% of the cervical cancer samples examined and inversely correlated with the expression of Ki-67, a marker of cell proliferation. Gain-of-function and loss-of-function studies in human cervical cancer, Caski and SiHa cells, demonstrated that miR-506 acts as a tumor suppressor by inhibiting cervical cancer growth in vitro and in vivo. Further studies showed that miR-506 induced cell cycle arrest at the G1/S transition, and enhanced apoptosis and chemosensitivity of cervical cancer cell.
    [Show full text]
  • Distinct Activities of Gli1 and Gli2 in the Absence of Ift88 and the Primary Cilia
    Journal of Developmental Biology Article Distinct Activities of Gli1 and Gli2 in the Absence of Ift88 and the Primary Cilia Yuan Wang 1,2,†, Huiqing Zeng 1,† and Aimin Liu 1,* 1 Department of Biology, Eberly College of Sciences, Center for Cellular Dynamics, Huck Institute of Life Science, The Penn State University, University Park, PA 16802, USA; [email protected] (Y.W.); [email protected] (H.Z.) 2 Department of Occupational Health, School of Public Health, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang 110122, China * Correspondence: [email protected]; Tel.: +1-814-865-7043 † These authors contributed equally to this work. Received: 2 November 2018; Accepted: 16 February 2019; Published: 19 February 2019 Abstract: The primary cilia play essential roles in Hh-dependent Gli2 activation and Gli3 proteolytic processing in mammals. However, the roles of the cilia in Gli1 activation remain unresolved due to the loss of Gli1 transcription in cilia mutant embryos, and the inability to address this question by overexpression in cultured cells. Here, we address the roles of the cilia in Gli1 activation by expressing Gli1 from the Gli2 locus in mouse embryos. We find that the maximal activation of Gli1 depends on the cilia, but partial activation of Gli1 by Smo-mediated Hh signaling exists in the absence of the cilia. Combined with reduced Gli3 repressors, this partial activation of Gli1 leads to dorsal expansion of V3 interneuron and motor neuron domains in the absence of the cilia. Moreover, expressing Gli1 from the Gli2 locus in the presence of reduced Sufu has no recognizable impact on neural tube patterning, suggesting an imbalance between the dosages of Gli and Sufu does not explain the extra Gli1 activity.
    [Show full text]